Pediatrics

(225) A systematic review and network meta-analysis of gamification approach for attention-deficit hyperactivity disorder in children and adolescents focusing on digital therapeutics

(226) Adrenocorticotropic hormone versus prednisolone for infantile spasms: a systematic review and economic evaluation

(228) Beta-blocker-associated Hypoglycemia in Pediatric Patients: Findings from the FDA Adverse Event Reporting System, National Poison Data System, Medical Literature, and Sentinel Distributed Database

(229) Characterizing incident antidepressant use in young people in Norway: pathways to treatment and follow-up in specialist healthcare

(230) Characterizing Infants in the Sentinel Distributed Database Mother-Infant Linkage Table

(231) Characterizing inpatient electronic health records (EHR) from a large hospital network for use in neonatal pharmacoepidemiology studies in the United States

(232) Characterizing Pediatric Members in the Sentinel Distributed Database: An Update with Data from Medicaid

(234) Dosing of antidepressants in relation to body weight in children and adolescents with overweight and obesity- a population-based study

(235) Drug utilization in children at a German university hospital – Are evidence-based (off-label) dosing recommendations available?

(236) Increased Prescribing of Neuroleptics to Children in Sweden

(237) Infant Growth and Development Outcomes among Commercially Insured Infants in the United States, 2016 – 2023

(241) Pediatric cancer in the United States: a comparison of two data sources

(242) Performance of Disease Activity Monitoring in Individuals with Childhood-Onset Lupus Nephritis in the United States

(244) Psychotropic drug use among 0-17 year old Norwegians during 2014-2021: a nationwide register study

(245) Psychotropic Drug Utilization Patterns among Children and Adolescents in British Columbia, Canada: Sex Differences in Drug Initiation

(246) Quality assessment of medication data from routine paediatric inpatient documentation – A prerequisite for drug utilisation studies

(247) Relative age effect on ADHD diagnosis, medication prescription, and persistence: a population-based study within a birth cohort

(248) Surveillance of outcomes identified with use of biologics indicated for asthma: a comparison of events observed with pediatric utilization

(249) The importance of the analysis of multiple databanks for the valid estimation of thrombocytopenia incidence rates in children in BIFAP data source (Spain).

(250) The Pharmacotherapy Options for Attention-Deficit Hyperactivity Disorder (ADHD) in Taiwan and the Influencing Factors

(251) The real-world use of medicines for the management of haematological malignancies in paediatric populations: an international scoping review.

(252) Trends in Childhood BMI, Overweight, and Obesity among 7-year-old Girls during the Last Six Decades

(253) Trends in distal radius fractures in Japanese children 2007-2021

(254) Trends in New Use of Disease-Modifying Antirheumatic Drugs Among Children with Juvenile Idiopathic Arthritis in the United States, 2001-2022

(255) Trends of Antidepressant Use Among Children in Commercial and Public Payer Systems in the United States, 2001-2019

(257) Within-Trial Interviews to Contextualize the Patient Experience and Supplement Clinical Outcomes Assessments in a Pivotal Trial of a Newly Described, Fatal and Ultra-Rare Pediatric Disease